Search Results - Nathan Constantine‐Cooke
- Showing 1 - 3 results of 3
-
1
Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study by Alexander T. Elford, Maria Bishara, Nikolas Plevris, Beatriz Gros, Nathan Constantine‐Cooke, James Goodhand, Nicholas A. Kennedy, Tariq Ahmad, Charlie W. Lees
Published 2024Artigo -
2
Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort by Beatriz Gros, Nikolas Plevris, Nathan Constantine‐Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian Arnott, Gareth‐Rhys Jones, Charlie W. Lees, L Derikx
Published 2023Artigo -
3
Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis by Beatriz Gros, Mairi Goodall, Nikolas Plevris, Nathan Constantine‐Cooke, Alexander T. Elford, Claire O’Hare, Colin Noble, Gareth‐Rhys Jones, Ian Arnott, Charlie W. Lees
Published 2023Artigo
Search Tools:
Related Subjects
Calprotectin
Cohort
Disease
Faecal calprotectin
Inflammatory bowel disease
Internal medicine
Medicine
Adverse effect
Gastroenterology
Infliximab
Retrospective cohort study
Ulcerative colitis
Biosimilar
Clinical endpoint
Clinical trial
Cohort study
Colitis
Crohn's disease
Discontinuation
Mercaptopurine
Surgery
Thiopurine methyltransferase